Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06691152 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy and Safety of CD19 UCAR T Cells in Refractory Systemic Lupus Erythematosus

Name: Efficacy and Safety of CD19 UCAR T Cells in Refractory Systemic Lupus Erythematosus — clinical trial record (NCT06691152)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: SLE

StatusRecruiting

PhasePhase 1

SponsorThe Children's Hospital of Zhejiang University School of Medicine

Started2024-10-30

View on ClinicalTrials.gov ↗

The Children's Hospital of Zhejiang University School of Medicine

58 trials monitored

See all monitored trials

Lupus (SLE)

648 trials monitored

See 25 trials at risk

This is an investigator-initiated trial to evaluate the safety and efficacy of CD19 Universal CAR-T cells in the treatment of refractory systemic lupus erythematosus.

Trial Details

NCT Number	NCT06691152
Lead Sponsor	The Children's Hospital of Zhejiang University School of Medicine
Conditions	Systemic Lupus Erythematosus
Enrollment	18 participants
Start Date	2024-10-30
Primary Completion	2027-09-30 (estimated)
Study Completion	2027-09-30 (estimated)
Updated on ClinicalTrials.gov	2024-11-15